[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100420209":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":23,"locations":28,"responsibleParty":61,"collaborators":10,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":69,"eligibilityCriteria":70,"healthyVolunteers":65,"sex":71,"minAge":72,"maxAge":73,"enrollmentInfo":74,"targetDuration":10,"studyType":77,"phases":10,"briefSummary":78,"conditions":79,"keywords":81,"overallStatus":31,"whyStopped":10,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"University Hospital, Toulouse","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"People with sensitization or allergy",null,"blood and urine will be collected during a blood test scheduled for the follow-up of the patient",[13],"Biological: collection of blood and urine",[15],{"type":16,"name":17,"description":11,"armGroupLabels":18,"otherNames":10},"BIOLOGICAL","collection of blood and urine",[9],[20],{"name":21,"affiliation":5,"role":22},"Marine Michelet, MD","PRINCIPAL_INVESTIGATOR",[24],{"name":21,"role":25,"phone":26,"phoneExt":10,"email":27},"CONTACT","33-5 34 55 85 85","michelet.m@chu-toulouse.fr",[29,50],{"facility":30,"status":31,"city":32,"state":10,"zip":33,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"University Hospital","RECRUITING","Toulouse","31000","France","FR",{"type":37,"coordinates":38},"Point",[39,40],1.44367,43.60426,{"lat":40,"lon":39},[43,46],{"name":21,"role":25,"phone":44,"phoneExt":45,"email":27},"5 34 55 85 86","0033",{"name":47,"role":25,"phone":48,"phoneExt":45,"email":49},"Françoise Auriol, PhD","561779103","auriol.f@chu-toulouse.fr",{"facility":51,"status":31,"city":32,"state":10,"zip":52,"country":34,"countryCode":35,"cosmosGeoPoint":53,"geoPoint":55,"contacts":56},"Larrey hospital","31059",{"type":37,"coordinates":54},[39,40],{"lat":40,"lon":39},[57],{"name":58,"role":25,"phone":59,"phoneExt":45,"email":60},"Laurent Guilleminault, MD","567771624","guilleminault.l@chu-toulouse.fr",{"type":62,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100420209","feasibility-study-of-a-new-immunoglobulin-e-ige-assay-method-100420209",false,"NCT04751760","Feasibility Study of a New Immunoglobulin E (IgE) Assay Method","Feasibility Study of a New Immunoglobulin E (IgE) Assay Method in Urine and Blood","LuLISA","Inclusion Criteria:\n\n* Males or females 6 months' old or older\n* Sensitization or allergy towards a trophallergen, an aeroallergen, hymenoptera venom or drug proven by:\n\n  * positive skin test (s)\n  * and \u002F or IgE specific (s)\\> 0.1 kUA \u002F L\n  * and \u002F or anamnesis in favor of an allergic reaction of mediated IgE\n* Social coverage up to date\n\nExclusion Criteria:\n\n* Children younger than 6 months'old\n* Children's weight less than 10 kg\n* Pregnant or breastfeeding women\n* Patients with cystic fibrosis\n* Patients with dysimmune or autoimmune pathology\n* Anamnesis in favor of a delayed allergy or a contact allergy.","ALL","6 Months","99 Years",{"count":75,"type":76},1376,"ESTIMATED","OBSERVATIONAL","The main objective is to study the feasibility of a new specific IgE assay using a bioluminescence technique in a pediatric and adult allergic population. For this, we will collect blood, and urine during a blood test scheduled for the follow-up of the patient.",[80],"Allergy and Immunology",[82,83,84,85],"IgE assay","food allergy\u002F hypersensitivity","respiratory allergy\u002F hypersensitivity","hymenopter allergy\u002F hypersensitivity","2026-03-16",{"date":88,"type":89},"2026-03-19","ACTUAL",{"date":91,"type":89},"2021-04-20",{"date":93,"type":76},"2026-04-20",{"name":5,"class":6},2]